WO2021017839A1 - External skin composition having anti-acne effect - Google Patents

External skin composition having anti-acne effect Download PDF

Info

Publication number
WO2021017839A1
WO2021017839A1 PCT/CN2020/102233 CN2020102233W WO2021017839A1 WO 2021017839 A1 WO2021017839 A1 WO 2021017839A1 CN 2020102233 W CN2020102233 W CN 2020102233W WO 2021017839 A1 WO2021017839 A1 WO 2021017839A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
extract
skin
birch
birch sap
Prior art date
Application number
PCT/CN2020/102233
Other languages
French (fr)
Chinese (zh)
Inventor
赵瑞丽
王莎莎
Original Assignee
浙江养生堂天然药物研究所有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江养生堂天然药物研究所有限公司 filed Critical 浙江养生堂天然药物研究所有限公司
Priority to JP2022506271A priority Critical patent/JP7422214B2/en
Priority to KR1020227006692A priority patent/KR20220044764A/en
Publication of WO2021017839A1 publication Critical patent/WO2021017839A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/591Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596

Definitions

  • the present invention relates to an external skin composition with anti-acne effect, which comprises (A) concentrated birch tree juice with a concentration ratio of about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times , And (B) one or more substances selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide.
  • Acne also known as acne, acne, acne, acne, etc.
  • Acne has a high incidence, often lasts for a long time, and is easy to recur. For some acne, if treatment is not taken in time, it will cause hyperpigmentation and even scarring, which will seriously affect the patient's appearance and bring serious negative effects on the patient's psychology.
  • the pathogenic factors of acne include excessive androgen levels, increased sebum secretion, hyperkeratosis of the hair follicle duct, and excessive proliferation of Propionibacterium acnes.
  • medicinal anti-acne products mostly use androgen antagonists, P. acnes inhibitors, and tretinoin drugs.
  • the toxic and side effects are also relatively large, which may cause liver damage or even cause infant deformity.
  • Acne-repellent cosmetics are currently the first choice for acne prevention and treatment by consumers.
  • acne-removing cosmetics currently on the market generally suffer from deficiencies such as slow effectiveness, insignificant acne-removing effects, and even irritation. Therefore, finding safe and effective anti-acne active substances based on the physiological and pathological characteristics of acne is a hot spot in the development of anti-acne cosmetics, and it is also the direction of joint efforts of cosmetics practitioners.
  • Birch sap is the sap from the birch family plant, rich in active ingredients such as polysaccharides, amino acids, vitamins, biotin, cytokinins, minerals and trace elements needed by the human body.
  • active ingredients such as polysaccharides, amino acids, vitamins, biotin, cytokinins, minerals and trace elements needed by the human body.
  • the use of birch (European white birch) sap to wash your face in Europe has been reported to help improve facial acne.
  • Naturally sourced birch sap used alone or in combination with other active substances has great potential in the field of anti-acne.
  • the present invention relates to (A) concentrated birch tree juice and (B) selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide
  • concentration of the concentrated birch tree juice is about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times.
  • the present invention relates to a skin external composition with anti-acne effect, which comprises (A) concentrated birch tree juice, the concentration of which is about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times, and (B) one or more substances selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate, and nicotinamide.
  • the pathogenesis of acne involves excessive androgen levels, increased sebum secretion, hyperkeratosis of the hair follicle duct, and proliferation of Propionibacterium acnes. Effectively reduce the exuberant sebum secretion caused by male hormones, prevent the proliferation of P. acnes and hyperkeratosis of the hair follicle mouth, and inhibit the resulting inflammation, which is the key to the treatment of acne.
  • the inventors found that compared with the use of concentrated birch tree juice or salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate, and nicotinamide alone,
  • the combination of concentrated birch juice with salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and/or nicotinamide has significantly better anti-acne efficacy, much higher than
  • the superimposing effect of the two functions is specifically manifested in the ability to effectively inhibit the activity of 5 ⁇ -reductase, thereby reducing the production of dihydrotestosterone, reducing the secretion of oil, and effectively inhibiting the proliferation of Propionibacterium acnes and reducing the inflammation caused by it.
  • IL-1 ⁇ and TNF- ⁇ it shows better anti-acne effect.
  • the birch sap involved in the present invention is obtained from the genus Betula, Betula alba, Betula pubescens, Betula pendula and Asian white birch (Betula platyphylla). Varieties.
  • the birch sap is a colorless, transparent, no-sediment-free, and nutrient-rich sap that is artificially collected by drilling holes in the base of the birch trunk between thawing and early spring.
  • the birch sap is commercially available and used as it is, for example, it can be purchased from Daxinganling Chaoyue Wild Berry Development Co., Ltd.
  • the concentrated birch sap in the present invention is obtained by concentrating the above-mentioned commercial products. Concentration methods are known in the art, such as heating concentration, low-temperature vacuum concentration, membrane concentration and the like. In the present invention, the concentration is preferably carried out by a low-temperature freeze concentration or membrane concentration process. For example, the commercially available birch juice stock solution is input into a low-temperature drying equipment, the temperature is lowered to -40°C to -70°C, and the vacuum is applied to 0.1-30Pa. Concentrated in vacuum at low temperature to obtain concentrated birch sap with different concentration times.
  • controlling the concentration ratio of birch sap is critical.
  • controlling the concentration ratio of birch sap is about 1.1-8 times, preferably 1.2-4 times, more preferably 1.2-2 times.
  • the content of the (A) concentrated birch sap is about 10-98% by weight, preferably about 20-98% by weight, more preferably about 30-97% by weight, based on the total amount of the skin external composition with anti-acne effect weight.
  • the component (B) salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide are known in the art, and they are all commercially available, Used in the present invention as it is.
  • the total content of the component (B) is about 0.0005-30% by weight, preferably about 0.001-10% by weight, more preferably about 0.1-5% by weight, most preferably about 0.5-3% by weight, based on the anti-acne effect
  • the total weight of the skin topical composition is about 0.0005-30% by weight, preferably about 0.001-10% by weight, more preferably about 0.1-5% by weight, most preferably about 0.5-3% by weight, based on the anti-acne effect.
  • the external skin composition includes a pharmaceutical composition and a cosmetic composition, especially a skin care cosmetic composition.
  • the external skin composition does not contain any added water, but does not exclude the moisture inherently contained in each component.
  • the external skin composition does not contain chelating agents such as EDTA salt, sodium polyphosphate, sodium metaphosphate, and gluconic acid.
  • chelating agents such as EDTA salt, sodium polyphosphate, sodium metaphosphate, and gluconic acid.
  • the skin external composition may optionally include component (C) commonly used ingredients in pharmaceutical compositions or cosmetic compositions, including vehicles, active ingredients and Accessories etc.
  • component (C) is known in the art, and those skilled in the art can select its type and amount according to needs.
  • the content of component (C) is usually about 0-70% by weight, based on the total of the composition. weight.
  • the vehicle includes, for example, a diluent, a dispersant, or a carrier, and examples thereof include, but are not limited to, ethanol, dipropylene glycol, butylene glycol, and the like.
  • the content of the vehicle in the cosmetic composition is known in the art, for example, it usually accounts for 0.5-20% of the total weight of component (C).
  • the active ingredients include antibacterial agents, anti-inflammatory agents, astringents, antioxidants, moisturizers, emollients, oil control agents, exfoliating ingredients and the like.
  • the antibacterial agents include, but are not limited to, ursolic acid, oldenlandia diffusa flavonoids, honeysuckle flower extract, tea tree essential oil, chitin, cinnamon twig extract, coral ginger volatile oil, clove extract, mushroom extract, aloe extract, One or more of mugwort leaf extract, 1-pentadecanol and its derivatives, cedarene, caryophyllene, and phyllene.
  • the content of the antibacterial agent in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
  • the anti-inflammatory agent includes, but is not limited to, safflower yellow, dipotassium glycyrrhizinate, cattail pollen extract, arrowroot extract, asiaticoside, allantoin, cucumber extract, garlic extract, burdock extract, white One or more of Veratrol, Sophora flavescens extract, Magnolia Bark extract, etc.
  • the content of the anti-inflammatory agent in the skin external composition is known in the art, for example, it usually accounts for 0.01-50% of the total weight of the component (C).
  • the astringent includes, but is not limited to, green tea polyphenols, witch hazel extract, vitamin A, menthol lactate, seaweed extract, indigo naturalis, sulfur, rehmannia, angelica, allantoin, lactic acid, tartaric acid, succinic acid One or more of citric acid, etc.
  • the content of the astringent in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
  • the antioxidants include, but are not limited to, white tea polyphenols, red moss alkaloids, hawthorn flavonoids, coenzyme Q10, grape seed extract, asparagus extract, radish extract, L-C stock solution, safflower water extract, Centella asiatica One or more of glycosides, Atractylodes polysaccharides, vitamin E and its derivatives.
  • the content of the antioxidant in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
  • moisturizer examples include, but are not limited to, glycerin, diglycerin, butylene glycol, propylene glycol, 1,3-propanediol, dipropylene glycol, 1,2-pentanediol, polyethylene glycol-8, polyethylene glycol Alcohol-32, methylglucitol-10, methylglucitol-20, PEG/PPG-17/6 copolymer, glycerol-7, glycerol-26, glycerol glucoside, PPG-10 methyl glucose ether, PPG-20 methyl glucose ether, PEG/PPG/polybutylene glycol-8/5/3 glycerin, sucrose, trehalose, rhamnose, mannose, raffinose, Betaine, erythritol, xylitol, urea, glyceryl polyether-5 lactate, sodium hyaluronate, hydrolyzed sodium hyaluronate, acetyl
  • emollient examples include, but are not limited to, olive oil, macadamia nut oil, sweet almond oil, grape seed oil, avocado oil, corn oil, sesame oil, soybean oil, peanut oil, white flower seed oil, safflower seed oil, Dogtooth rose hip oil, argan tree kernel oil, jojoba seed oil, sunflower seed oil, palm tree fruit oil, squalane, ethylhexyl palmitate, isopropyl myristate, hydrogenated polyisobutylene, isotene Hexane, isododecane, diethylhexyl carbonate, dioctyl carbonate, isopropyl lauroyl sarcosine, isononyl isononanoate, hydrogenated polydecene, glycerol tri(ethylhexanoate) , Cetyl alcohol ethyl hexanoate, bis-diethoxy diethylene glycol cyclohexane
  • solid emollients include, but are not limited to, cetyl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, scylitol, lauric acid, myristic acid, palmitic acid, stearic acid, beeswax, candelilla Tree wax, carnauba wax, lanolin, ozokerite, jojoba seed wax, paraffin wax, microcrystalline wax, hydrogenated rice bran wax, hydrogenated coconut oil glycerides, glyceryl behenate/eicosanate, myristyl alcohol One or more of myristate, bis-diglyceride polyacyl adipate-2, shea butter, and muluxing palm seed butter.
  • the content of the emollient in the skin external composition is known in the art, for example, it usually accounts for 1-50% of the total weight of component (C).
  • oil control agent examples include, but are not limited to, hawthorn extract, ivy extract, saxifrage extract, winter melon seed extract, spirea extract, vitamin B5, verbascum glycosides and puerarin, Japanese cypress leaf extract One or more of extracts, Salvia miltiorrhiza root extract, Ennan tomato bark extract, Willow orchid leaf extract, Dendrobium extract, Sage extract, Avocado extract, etc.
  • the content of the oil control agent in the external skin composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
  • the exfoliating ingredients include but are not limited to bromelain, salicylic acid, fruit acid, lactic acid, citric acid, enzyme cutin exfoliant, polyethylene beads, glycolic acid, mandelic acid, malic acid, tartaric acid, azelaic acid, acetic acid, etc.
  • the content of the exfoliating ingredient in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
  • the auxiliary materials include, for example, emulsifiers, thickeners, preservatives, perfumes and the like.
  • emulsifier examples include, but are not limited to, cetearyl oleate, sorbitan oleate, polysorbate-60, polysorbate-80, methylglucose sesquistearic acid Ester, PEG-20 methyl glucose sesquistearate, PEG-40 hydrogenated castor oil, PPG-26-butanol-26, PEG-4 polyglycerol-2 stearate, PEG-60 hydrogenated Castor oil, steareth-2, steareth-21, PPG-13-decyltetradeceth-24, cetearyl glucoside, PEG-100 stearate, glycerin Stearate, Glyceryl Stearate SE, Coco Glucoside, Ceteareth-25, PEG-40 Stearate, Polyglyceryl-3 Methyl Glucose Distearate, Glyceryl stearate citrate, polyglyceryl-10 stearate, polyglyceryl-10 myristate, polyglyce
  • the thickener examples include, but are not limited to, carbomers, acrylic acid (ester) and its derivatives, xanthan gum, gum arabic, polyethylene glycol-14M, polyethylene glycol-90M, succinyl poly One or more of high molecular polymers such as sugar, hydroxyethyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose.
  • the content of the thickener in the external skin composition is known in the art, for example, it usually accounts for 0.1-10% of the total weight of the component (C).
  • preservatives examples include, but are not limited to, methyl paraben, ethyl paraben, propyl paraben, phenoxyethanol, benzyl alcohol, phenethyl alcohol, bis(hydroxymethyl)imidazolidinyl urea, potassium sorbate, One or more of sodium benzoate, chlorphenesin, sodium dehydroacetate, etc.
  • the content of the preservative in the skin external composition is known in the art, for example, it usually accounts for 0.01-50% of the total weight of the component (C).
  • the skin external composition of the present invention can be prepared by any suitable method known in the art.
  • it can be prepared using equipment such as dissolving tanks, emulsifying pots, dispersers, and delivery pumps commonly used in the cosmetics field.
  • equipment such as dissolving tanks, emulsifying pots, dispersers, and delivery pumps commonly used in the cosmetics field.
  • When preparing put the water-soluble substance into the water-phase dissolving kettle, and the oil-soluble substance into the oil-phase dissolving kettle, and heat the temperature of the two kettles to about 80°C.
  • a disperser Pre-dispersion. After the dissolution is completed, the oil phase and the water phase are transported to the emulsifying pot for homogenization and emulsification for about 5-15 minutes. After the emulsification is completed, the temperature of the material body is reduced to normal temperature, optional flavors, preservatives, etc. are added, and the pH of the product is adjusted as necessary.
  • the products can be filled and shipped only after the
  • compositions or cosmetic compositions in various dosage forms such as liquids, emulsions, creams, creams or gels can be prepared according to needs, wherein the cosmetic compositions can be lotions, sprays, emulsions, essence water or essence milk, BB cream , Sunscreen and other forms.
  • Example 1 Inhibition of 5 ⁇ -reductase activity
  • the fresh white birch sap stock solution purchased from Daxinganling Chaoyue Wild Berry Development Co., Ltd. is fed into the low-temperature drying equipment, the temperature is reduced to -65°C, the vacuum is reduced to 0.1Pa, and the concentration is 2 and 10 times.
  • NADPH Reduced coenzyme II
  • Testosterone Elisa kit Wuhan Ulsheng Company (Cat. No.: CEA458Ge);
  • Phenylmethylsulfonyl fluoride (PMSF): American Sigma company;
  • DTT Dithiothreitol
  • the sample amount of a single raw material is one whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
  • the inhibition rate of 5 ⁇ -reductase is calculated according to the following formula:
  • I% ( ⁇ A 0 - ⁇ A n )/ ⁇ A 0 x100%
  • the birch sap, PCA zinc, and their compositions of different concentrations were tested by the antibacterial ring method.
  • Reagents nutrient agar medium; bacterial suspension.
  • Propionibacterium acnes was purchased from the China Type Culture Collection.
  • sample addition information the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
  • Preparation of antibacterial tablets take a circular sterile dry filter paper with a diameter of 5mm, drop 20 ⁇ L of liquid sample into the center of the antibacterial tablet, and then place the filter paper flat in a clean sterile plate with the lid open Dry in a constant temperature oven (37°C), or dry naturally at room temperature for later use.
  • test bacteria dip a sterile cotton swab into a test bacteria suspension with a concentration of 1 ⁇ 10 4 cfu/ml to 9 ⁇ 10 4 cfu/ml, and smear it evenly on the surface of the nutrient agar medium plate 3 times. After each application, the plate should be rotated 60 degrees, and finally use a cotton swab to apply a circle around the edge of the plate. Cover the plate and let it dry at room temperature for 5 minutes.
  • Placement of antibacterial test samples Place 1 stained plate for each test, 4 pieces of test specimens for each plate, 1 piece of control specimens, a total of 5 pieces.
  • use sterile tweezers to gently press the sample piece to make it close to the surface of the plate, cover the plate, place it in a 37°C incubator, and observe the results after incubating for 16 to 18 hours. Measure the diameter of the antibacterial ring (including the patch) with a vernier caliper and record it. The test was repeated 3 times.
  • Drugs and reagents 100% oleic acid; ELISA IL-1 ⁇ kit; ELISA TNF- ⁇ kit.
  • sample addition information the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
  • Modeling method The rats were randomly divided into 2 groups, of which 8 were in the normal group and the rest were modeled. Apply 100% oleic acid into the skin of each rat's right auricle with a 1ml syringe, once a day, about 0.3ml each time for 3 weeks. Apply 100% oleic acid to the 22nd day, randomly select 2 model rats, cut off the 2 ears of the right ear where the oleic acid is applied, fix with 10% formaldehyde, embed in paraffin, section, HE stain, light Observe histopathological changes under the microscope.
  • Example 4 Human skin oil content
  • SM815 a skin oil tester (SM815, a German CK company) was used to quantitatively measure the skin oil gland secretions before and after using cosmetics, which can evaluate the anti-acne efficacy of cosmetics.
  • the SM815 measurement principle is based on the photometer principle. After a special matt tape with a thickness of 0.1mm absorbs the oil on the human skin, it will become a translucent tape, and its light transmission will change and the absorbed grease The more, the greater the light transmission, so that the content of skin oil can be measured.
  • sample addition information the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
  • the skin oil content of the control group gradually increased over time, indicating that the tester had strong oil secretion.
  • the results of the sample group showed that compared with the birch sap stock solution alone, the birch sap of 2 times concentrated birch sap, PCA zinc, sodium hyaluronate, and the combination of birch sap stock and PCA zinc or sodium hyaluronate, the birch sap was 2 times concentrated.
  • the combined use of tree sap and PCA zinc or sodium hyaluronate more significantly inhibited the tester’s excessive oil secretion.
  • the birch sap is concentrated to 10 times, the effect of using it in combination with other active substances is significantly weakened, and is even inferior to the combined effect of birch sap stock and other active ingredients.
  • the preparation process is as follows: Weigh the raw materials of phase A, mix the components in phase A uniformly and ensure that the components are completely dissolved, heat to 60°C and keep it for 20 minutes. When the temperature is lowered to 45°C while stirring, add phase B one by one and stir evenly to obtain the above-mentioned various acne-removing essence milk products.
  • the classification criteria are as follows:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is an external skin composition having an anti-acne effect, comprising (A) a concentrated birch sap, the concentration factor thereof being about 1.1 - 8 times, preferably about 1.2 - 4 times, and more preferably about 1.2 - 2 times, and (B) one or more materials selected from salicylic acid, malic acid, an aloe extract, a green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide.

Description

具有祛痘功效的皮肤外用组合物External skin composition with anti-acne effect 技术领域Technical field
本发明涉及一种具有祛痘功效的皮肤外用组合物,其包含(A)浓缩的桦树汁,其浓缩倍数为约1.1-8倍,优选约1.2-4倍,更优选约1.2-2倍,和(B)选自水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺中的一种或多种物质。The present invention relates to an external skin composition with anti-acne effect, which comprises (A) concentrated birch tree juice with a concentration ratio of about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times , And (B) one or more substances selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide.
背景技术Background technique
痤疮,又被称为青春痘、痘痘、粉刺、暗疮等,是发生于毛囊皮脂腺单位的一种慢性炎症类皮肤病,好发于青少年,多发于面部、上胸背部、颈部等皮脂腺分泌旺盛部位,临床表现常以粉刺、丘疹、脓疱、结节等多形性皮损为特点,严重者还会形成瘢痕。痤疮发病率高,往往持续时间较久,且容易反复发作。有些痤疮,如果不及时采取治疗措施,将会造成色素沉着,甚至出现瘢痕,严重影响患者的容貌,并给患者心理带来严重的负面影响。Acne, also known as acne, acne, acne, acne, etc., is a chronic inflammatory skin disease that occurs in the sebaceous gland unit of the hair follicle. It is more common in adolescents, and often occurs in the sebaceous glands of the face, upper chest, back, and neck. In vigorous areas, the clinical manifestations are often characterized by pleomorphic skin lesions such as acne, papules, pustules, and nodules. In severe cases, scars may also form. Acne has a high incidence, often lasts for a long time, and is easy to recur. For some acne, if treatment is not taken in time, it will cause hyperpigmentation and even scarring, which will seriously affect the patient's appearance and bring serious negative effects on the patient's psychology.
目前普遍认为痤疮的发病因素有雄激素水平过高、皮脂分泌增加、毛囊导管过度角化、痤疮丙酸杆菌过度增殖。目前药用类祛痘产品多使用雄性激素拮抗剂、痤疮丙酸杆菌抑制剂、维A酸类药物等进行治疗,虽然疗效明显,但毒副作用也较大,可能会引起肝脏功能损伤,甚至导致胎儿畸形。祛痘类化妆品,是目前消费者首选的痤疮预防及治疗方式。而目前市面上销售的祛痘化妆品普遍存在见效慢、祛痘效果不明显,甚至出现刺激性等不足。因此以痤疮的生理病理特点为基础,寻找安全、有效的祛痘类活性物质,是祛痘化妆品开发的热点,也是化妆品从业人员共同努力的方向。At present, it is generally believed that the pathogenic factors of acne include excessive androgen levels, increased sebum secretion, hyperkeratosis of the hair follicle duct, and excessive proliferation of Propionibacterium acnes. At present, medicinal anti-acne products mostly use androgen antagonists, P. acnes inhibitors, and tretinoin drugs. Although the effect is obvious, the toxic and side effects are also relatively large, which may cause liver damage or even cause infant deformity. Acne-repellent cosmetics are currently the first choice for acne prevention and treatment by consumers. However, acne-removing cosmetics currently on the market generally suffer from deficiencies such as slow effectiveness, insignificant acne-removing effects, and even irritation. Therefore, finding safe and effective anti-acne active substances based on the physiological and pathological characteristics of acne is a hot spot in the development of anti-acne cosmetics, and it is also the direction of joint efforts of cosmetics practitioners.
桦树汁是从桦木科植物中流出的汁液,富含人体需要的多糖、氨基酸、维生素、生物素、细胞分裂素、矿物质和微量元素等活性成分。在欧洲使用桦树(欧洲白桦)树汁洗脸有助于改善面部痤疮的记载。天然来源的桦树汁单独使用或与其它活性物复配使用,在祛痘领域有巨大潜力。Birch sap is the sap from the birch family plant, rich in active ingredients such as polysaccharides, amino acids, vitamins, biotin, cytokinins, minerals and trace elements needed by the human body. The use of birch (European white birch) sap to wash your face in Europe has been reported to help improve facial acne. Naturally sourced birch sap used alone or in combination with other active substances has great potential in the field of anti-acne.
发明内容Summary of the invention
一方面,本发明涉及(A)浓缩的桦树汁与(B)选自水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺中的一种或多种的组合在具有祛痘功效的皮肤外用组合物中的用途,其中所述浓缩的桦树汁的浓缩倍数为约1.1-8倍,优选约1.2-4倍,更优选约1.2-2倍。In one aspect, the present invention relates to (A) concentrated birch tree juice and (B) selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide The use of one or more of the combination in the skin external composition with anti-acne effect, wherein the concentration of the concentrated birch tree juice is about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times.
另一方面,本发明涉及一种具有祛痘功效的皮肤外用组合物,其包含(A)浓缩的桦树汁,其浓缩倍数为约1.1-8倍,优选约1.2-4倍,更优选约1.2-2倍,和(B)选自水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺中的一种或多种物质。In another aspect, the present invention relates to a skin external composition with anti-acne effect, which comprises (A) concentrated birch tree juice, the concentration of which is about 1.1-8 times, preferably about 1.2-4 times, more preferably about 1.2-2 times, and (B) one or more substances selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate, and nicotinamide.
痤疮的发病机制涉及雄激素水平过高、皮脂分泌增加、毛囊导管过度角化、痤疮丙酸杆菌增殖等。有效降低雄性激素引起的皮脂分泌旺盛,防止痤疮丙酸杆菌增生及毛囊口过度角化并抑制由此产生的炎症反应,是治疗痤疮的关键所在。The pathogenesis of acne involves excessive androgen levels, increased sebum secretion, hyperkeratosis of the hair follicle duct, and proliferation of Propionibacterium acnes. Effectively reduce the exuberant sebum secretion caused by male hormones, prevent the proliferation of P. acnes and hyperkeratosis of the hair follicle mouth, and inhibit the resulting inflammation, which is the key to the treatment of acne.
意料不到地,本发明人发现,与单独使用浓缩桦树汁或者水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠、烟酰胺相比,浓缩桦树汁与水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和/或烟酰胺的组合具有显著更好的祛痘功效,远高于二者功能叠加效果,具体表现为能够有效抑制5α-还原酶的活力,从而减少二氢睾酮的生成,减少油脂的分泌,还能有效抑制痤疮丙酸杆菌的增殖,降低由此引发的炎症反应中IL-1α、TNF-α的含量,从而显示出更好的祛痘功效。Unexpectedly, the inventors found that compared with the use of concentrated birch tree juice or salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate, and nicotinamide alone, The combination of concentrated birch juice with salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and/or nicotinamide has significantly better anti-acne efficacy, much higher than The superimposing effect of the two functions is specifically manifested in the ability to effectively inhibit the activity of 5α-reductase, thereby reducing the production of dihydrotestosterone, reducing the secretion of oil, and effectively inhibiting the proliferation of Propionibacterium acnes and reducing the inflammation caused by it. In the content of IL-1α and TNF-α, it shows better anti-acne effect.
本发明中所涉及的桦树汁得自桦木科桦树属,其可来自白桦(Betula alba)、柔毛桦(Betula pubescens)、垂枝桦(Betula pendula)和亚洲白桦(Betula platyphylla)这四个品种。所述桦树汁为在解冻至早春发叶之间,人工在桦树的树干基部钻孔收集而得的无色透明、无沉淀、无杂物,具有桦树清香且营养丰富的汁液。所述桦树汁可商购获得并原样采用,例如可购自大兴安岭超越野生浆果开发有限责任公司。The birch sap involved in the present invention is obtained from the genus Betula, Betula alba, Betula pubescens, Betula pendula and Asian white birch (Betula platyphylla). Varieties. The birch sap is a colorless, transparent, no-sediment-free, and nutrient-rich sap that is artificially collected by drilling holes in the base of the birch trunk between thawing and early spring. The birch sap is commercially available and used as it is, for example, it can be purchased from Daxinganling Chaoyue Wild Berry Development Co., Ltd.
本发明中的浓缩桦树汁是将上述商购产品浓缩得到的。浓缩方法是本领域已知的,例如加热浓缩、低温真空浓缩、膜浓缩等。在本发明中,优选通过低温冷冻浓缩或膜浓缩工艺进行浓缩,例如,将商购的桦树汁原液输入低温干燥设备,降温至-40℃至-70℃,抽真空至0.1-30Pa而进行低温真空浓缩,从而得到不同浓缩倍数的浓缩桦树汁。The concentrated birch sap in the present invention is obtained by concentrating the above-mentioned commercial products. Concentration methods are known in the art, such as heating concentration, low-temperature vacuum concentration, membrane concentration and the like. In the present invention, the concentration is preferably carried out by a low-temperature freeze concentration or membrane concentration process. For example, the commercially available birch juice stock solution is input into a low-temperature drying equipment, the temperature is lowered to -40°C to -70°C, and the vacuum is applied to 0.1-30Pa. Concentrated in vacuum at low temperature to obtain concentrated birch sap with different concentration times.
进一步地,本发明人还发现,浓缩桦树汁的祛痘功效与其浓缩程度并非简单的线性关系,而是随着浓缩倍数增加而呈现先增加后下降的趋势。因此,控制桦树汁的浓缩倍数是关键的,在本发明中,控制桦树汁的浓缩倍数为约1.1-8倍,优选1.2-4倍,更优选1.2-2倍。Furthermore, the inventors also found that the acne-removing effect of concentrated birch sap and its concentration degree is not a simple linear relationship, but as the concentration ratio increases, it first increases and then decreases. Therefore, controlling the concentration ratio of birch sap is critical. In the present invention, controlling the concentration ratio of birch sap is about 1.1-8 times, preferably 1.2-4 times, more preferably 1.2-2 times.
所述(A)浓缩桦树汁的含量为约10-98%重量,优选约20-98%重量,更优选约30-97%重量,基于所述具有祛痘功效的皮肤外用组合物的总重量。The content of the (A) concentrated birch sap is about 10-98% by weight, preferably about 20-98% by weight, more preferably about 30-97% by weight, based on the total amount of the skin external composition with anti-acne effect weight.
所述组分(B)水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺是本领域已知的,它们均可以商购获得,原样用于本发明。The component (B) salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide are known in the art, and they are all commercially available, Used in the present invention as it is.
所述组分(B)总含量为约0.0005-30%重量,优选约0.001-10%重量,更优选约0.1-5%重量,最优选约0.5-3%重量,基于所述具有祛痘功效的皮肤外用组合物的总重量。The total content of the component (B) is about 0.0005-30% by weight, preferably about 0.001-10% by weight, more preferably about 0.1-5% by weight, most preferably about 0.5-3% by weight, based on the anti-acne effect The total weight of the skin topical composition.
所述皮肤外用组合物包括药物组合物和化妆品组合物,尤其是护肤化妆品组合物。The external skin composition includes a pharmaceutical composition and a cosmetic composition, especially a skin care cosmetic composition.
所述皮肤外用组合物不包含任何外加的水,但不排除各组分中固有地包含的水分。The external skin composition does not contain any added water, but does not exclude the moisture inherently contained in each component.
优选地,所述皮肤外用组合物不包含EDTA盐、多磷酸钠、偏磷酸钠、葡萄糖酸等螯合剂。Preferably, the external skin composition does not contain chelating agents such as EDTA salt, sodium polyphosphate, sodium metaphosphate, and gluconic acid.
除了上述组分(A)和(B)外,所述皮肤外用组合物还可以任选地包含组分(C)药物组合物或者化妆品组合物中常用的成分,其中包括媒介物、活性成分和辅料等。组分(C)是本领域已知的,本领域技术人员可根据需要选择其类型和用量,例如,组分(C)的含量通常 为约0-70%重量,基于所述组合物的总重量。In addition to the aforementioned components (A) and (B), the skin external composition may optionally include component (C) commonly used ingredients in pharmaceutical compositions or cosmetic compositions, including vehicles, active ingredients and Accessories etc. Component (C) is known in the art, and those skilled in the art can select its type and amount according to needs. For example, the content of component (C) is usually about 0-70% by weight, based on the total of the composition. weight.
所述媒介物包括例如稀释剂、分散剂或载体等,其实例包括但不限于乙醇、双丙甘醇、丁二醇等。所述媒介物在所述化妆品组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.5-20%。The vehicle includes, for example, a diluent, a dispersant, or a carrier, and examples thereof include, but are not limited to, ethanol, dipropylene glycol, butylene glycol, and the like. The content of the vehicle in the cosmetic composition is known in the art, for example, it usually accounts for 0.5-20% of the total weight of component (C).
所述活性成分包括抗菌剂、抗炎剂、收敛剂、抗氧化剂、保湿剂、润肤剂、控油剂、去角质成分等。The active ingredients include antibacterial agents, anti-inflammatory agents, astringents, antioxidants, moisturizers, emollients, oil control agents, exfoliating ingredients and the like.
所述抗菌剂包括但不限于熊果酸、白花蛇舌草黄酮、忍冬花提取物、茶树精油、甲壳素、桂枝提取物、珊瑚姜挥发油、丁香提取物、蘑菇提取物、芦荟提取物、艾叶提取物、1-十五醇及其衍生物、雪松烯、石竹烯、长叶烯等中的一种或多种。所述抗菌剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-30%。The antibacterial agents include, but are not limited to, ursolic acid, oldenlandia diffusa flavonoids, honeysuckle flower extract, tea tree essential oil, chitin, cinnamon twig extract, coral ginger volatile oil, clove extract, mushroom extract, aloe extract, One or more of mugwort leaf extract, 1-pentadecanol and its derivatives, cedarene, caryophyllene, and phyllene. The content of the antibacterial agent in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
所述抗炎剂包括但不限于红花黄色素、甘草酸二钾、蒲花粉提取物、矢藤提取物、积雪草苷、尿囊素、黄瓜提取物、大蒜提取物、牛蒡提取物、白藜芦醇、苦参提取液、厚朴提取物等中的一种或多种。所述抗炎剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-50%。The anti-inflammatory agent includes, but is not limited to, safflower yellow, dipotassium glycyrrhizinate, cattail pollen extract, arrowroot extract, asiaticoside, allantoin, cucumber extract, garlic extract, burdock extract, white One or more of Veratrol, Sophora flavescens extract, Magnolia Bark extract, etc. The content of the anti-inflammatory agent in the skin external composition is known in the art, for example, it usually accounts for 0.01-50% of the total weight of the component (C).
所述收敛剂包括但不限于绿茶多酚、金缕梅提取物、维生素A、薄荷醇乳酸酯、海藻萃取物、青黛、硫磺、生地黄、当归、尿囊素、乳酸、酒石酸、琥珀酸、柠檬酸等中的一种或多种。所述收敛剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-30%。The astringent includes, but is not limited to, green tea polyphenols, witch hazel extract, vitamin A, menthol lactate, seaweed extract, indigo naturalis, sulfur, rehmannia, angelica, allantoin, lactic acid, tartaric acid, succinic acid One or more of citric acid, etc. The content of the astringent in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
所述抗氧化剂包括但不限于白茶多酚、红茂草生物碱、山楂黄酮、辅酶Q10、葡萄籽提取物、芦笋提取物、萝卜提取物、左旋C原液、红花水提物、积雪草苷、白术多糖、维生素E及其衍生物等中的一种或多种。所述抗氧化剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-30%。The antioxidants include, but are not limited to, white tea polyphenols, red moss alkaloids, hawthorn flavonoids, coenzyme Q10, grape seed extract, asparagus extract, radish extract, L-C stock solution, safflower water extract, Centella asiatica One or more of glycosides, Atractylodes polysaccharides, vitamin E and its derivatives. The content of the antioxidant in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
所述保湿剂的实例包括但不限于甘油、双甘油、丁二醇、丙二醇、1,3-丙二醇、双丙甘醇、1,2-戊二醇、聚乙二醇-8、聚乙二醇-32、甲基葡糖醇聚醚-10、甲基葡糖醇聚醚-20、PEG/PPG-17/6共聚物、甘油聚醚-7、甘油聚醚-26、甘油葡糖苷、PPG-10甲基葡糖醚、PPG-20甲基葡糖醚、PEG/PPG/聚丁二醇-8/5/3甘油、蔗糖、海藻糖、鼠李糖、甘露糖、棉子糖、甜菜碱、赤藓醇、木糖醇、尿素、甘油聚醚-5乳酸酯、透明质酸钠、水解透明质酸钠、乙酰化透明质酸钠、聚谷氨酸钠、水解小核菌胶、出芽短梗酶多糖、银耳多糖、酸豆籽多糖等中的一种或多种。所述保湿剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的1-30%。Examples of the moisturizer include, but are not limited to, glycerin, diglycerin, butylene glycol, propylene glycol, 1,3-propanediol, dipropylene glycol, 1,2-pentanediol, polyethylene glycol-8, polyethylene glycol Alcohol-32, methylglucitol-10, methylglucitol-20, PEG/PPG-17/6 copolymer, glycerol-7, glycerol-26, glycerol glucoside, PPG-10 methyl glucose ether, PPG-20 methyl glucose ether, PEG/PPG/polybutylene glycol-8/5/3 glycerin, sucrose, trehalose, rhamnose, mannose, raffinose, Betaine, erythritol, xylitol, urea, glyceryl polyether-5 lactate, sodium hyaluronate, hydrolyzed sodium hyaluronate, acetylated sodium hyaluronate, sodium polyglutamate, Sclerotium hydrolysate One or more of gum, short-stemming enzyme polysaccharide, tremella polysaccharide, caper seed polysaccharide, etc. The content of the moisturizer in the skin external composition is known in the art, for example, it usually accounts for 1-30% of the total weight of the component (C).
所述润肤剂的实例包括但不限于橄榄油、澳洲坚果油、甜杏仁油、葡萄籽油、鳄梨油、玉米油、芝麻油、大豆油、花生油、白池花籽油、红花籽油、狗牙蔷薇果油、刺阿干树仁油、霍霍巴籽油、向日葵籽油、毛瑞榈果油、角鲨烷、棕榈酸乙基己酯、肉豆蔻酸异丙酯、氢化聚异丁烯、异十六烷、异十二烷、碳酸二乙基己酯、碳酸二辛酯、月桂酰肌氨酸异丙酯、异壬酸异壬酯、氢化聚癸烯、甘油三(乙基己酸)酯、鲸蜡醇乙基己酸酯、双-二乙氧基二甘醇环己烷1,4-二羧酸酯、辛酸/癸酸甘油三酯、油醇芥酸酯、辛基十二醇肉豆蔻酸 酯、辛基十二醇、聚二甲基硅氧烷、辛基聚甲基硅氧烷、鲸蜡基聚二甲基硅氧烷、环五聚二甲基硅氧烷等的一种或多种。固体润肤剂的实例包括但不限于鲸蜡醇、硬脂醇、鲸蜡硬脂醇、山嵛醇、鲨肝醇、月桂酸、肉豆蔻酸、棕榈酸、硬脂酸、蜂蜡、小烛树蜡、巴西棕榈蜡、羊毛脂、地蜡、霍霍巴籽蜡、石蜡、微晶蜡、氢化米糠蜡、氢化椰油甘油酯类、甘油山嵛酸酯/二十酸酯、肉豆蔻醇肉豆蔻酸酯、双-二甘油多酰基己二酸酯-2、牛油果树果脂、木鲁星果棕籽脂等中的一种或多种。所述润肤剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的1-50%。Examples of the emollient include, but are not limited to, olive oil, macadamia nut oil, sweet almond oil, grape seed oil, avocado oil, corn oil, sesame oil, soybean oil, peanut oil, white flower seed oil, safflower seed oil, Dogtooth rose hip oil, argan tree kernel oil, jojoba seed oil, sunflower seed oil, palm tree fruit oil, squalane, ethylhexyl palmitate, isopropyl myristate, hydrogenated polyisobutylene, isotene Hexane, isododecane, diethylhexyl carbonate, dioctyl carbonate, isopropyl lauroyl sarcosine, isononyl isononanoate, hydrogenated polydecene, glycerol tri(ethylhexanoate) , Cetyl alcohol ethyl hexanoate, bis-diethoxy diethylene glycol cyclohexane 1,4-dicarboxylate, caprylic/capric triglyceride, oleyl erucate, octyldodecanol Myristate, Octyldodecanol, Dimethicone, Octyl Dimethicone, Cetyl Dimethicone, Cyclopenta Dimethicone, etc. One or more. Examples of solid emollients include, but are not limited to, cetyl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, scylitol, lauric acid, myristic acid, palmitic acid, stearic acid, beeswax, candelilla Tree wax, carnauba wax, lanolin, ozokerite, jojoba seed wax, paraffin wax, microcrystalline wax, hydrogenated rice bran wax, hydrogenated coconut oil glycerides, glyceryl behenate/eicosanate, myristyl alcohol One or more of myristate, bis-diglyceride polyacyl adipate-2, shea butter, and muluxing palm seed butter. The content of the emollient in the skin external composition is known in the art, for example, it usually accounts for 1-50% of the total weight of component (C).
所述控油剂的实例包括但不限于山楂提取物、常青藤提取物、虎耳草提取物、冬瓜子提取物、榆绣线菊提取物、维生素B5、毛蕊异黄酮苷和葛根素、日本扁柏叶提取物、丹参根提取物、绿花恩南蕃茄树皮提取物、柳兰叶提取物、石斛提取物、鼠尾草提取物、鳄梨提取物等中的一种或多种。所述控油剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-30%。Examples of the oil control agent include, but are not limited to, hawthorn extract, ivy extract, saxifrage extract, winter melon seed extract, spirea extract, vitamin B5, verbascum glycosides and puerarin, Japanese cypress leaf extract One or more of extracts, Salvia miltiorrhiza root extract, Ennan tomato bark extract, Willow orchid leaf extract, Dendrobium extract, Sage extract, Avocado extract, etc. The content of the oil control agent in the external skin composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
所述去角质成分包括但不限于菠萝蛋白酶、水杨酸、果酸、乳酸、柠檬酸、酶角质剥脱剂、聚乙烯珠、乙醇酸、杏仁酸、苹果酸、酒石酸、壬二酸、乙酸等中的一种或多种。所述去角质成分在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-30%。The exfoliating ingredients include but are not limited to bromelain, salicylic acid, fruit acid, lactic acid, citric acid, enzyme cutin exfoliant, polyethylene beads, glycolic acid, mandelic acid, malic acid, tartaric acid, azelaic acid, acetic acid, etc. One or more of. The content of the exfoliating ingredient in the skin external composition is known in the art, for example, it usually accounts for 0.01-30% of the total weight of the component (C).
所述辅料包括例如乳化剂、增稠剂、防腐剂、香料等。The auxiliary materials include, for example, emulsifiers, thickeners, preservatives, perfumes and the like.
所述乳化剂的实例包括但不限于鲸蜡硬脂醇橄榄油酸酯、山梨坦橄榄油酸酯、聚山梨醇酯-60、聚山梨醇酯-80、甲基葡糖倍半硬脂酸酯、PEG-20甲基葡糖倍半硬脂酸酯、PEG-40氢化蓖麻油、PPG-26-丁醇聚醚-26、PEG-4聚甘油-2硬脂酸酯、PEG-60氢化蓖麻油、硬脂醇聚醚-2、硬脂醇聚醚-21、PPG-13-癸基十四醇聚醚-24、鲸蜡硬脂基葡糖苷、PEG-100硬脂酸酯、甘油硬脂酸酯、甘油硬脂酸酯SE、椰油基葡糖苷、鲸蜡硬脂醇聚醚-25、PEG-40硬脂酸酯、聚甘油-3甲基葡糖二硬脂酸酯、甘油硬脂酸酯柠檬酸酯、聚甘油-10硬脂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10二油酸酯、聚甘油-10月桂酸酯、聚甘油-10异硬脂酸酯、聚甘油-10油酸酯、聚甘油-10二异硬脂酸酯、聚甘油-6月桂酸酯、聚甘油-6肉豆蔻酸酯、蔗糖硬脂酸酯、蔗糖多硬脂酸酯等中的一种或多种。所述乳化剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.5-10%。Examples of the emulsifier include, but are not limited to, cetearyl oleate, sorbitan oleate, polysorbate-60, polysorbate-80, methylglucose sesquistearic acid Ester, PEG-20 methyl glucose sesquistearate, PEG-40 hydrogenated castor oil, PPG-26-butanol-26, PEG-4 polyglycerol-2 stearate, PEG-60 hydrogenated Castor oil, steareth-2, steareth-21, PPG-13-decyltetradeceth-24, cetearyl glucoside, PEG-100 stearate, glycerin Stearate, Glyceryl Stearate SE, Coco Glucoside, Ceteareth-25, PEG-40 Stearate, Polyglyceryl-3 Methyl Glucose Distearate, Glyceryl stearate citrate, polyglyceryl-10 stearate, polyglyceryl-10 myristate, polyglyceryl-10 dioleate, polyglyceryl-10 laurate, polyglyceryl-10 isostearate Fatty acid ester, polyglyceryl-10 oleate, polyglyceryl-10 diisostearate, polyglyceryl-6 laurate, polyglyceryl-6 myristate, sucrose stearate, sucrose polystearate One or more of acid esters. The content of the emulsifier in the skin external composition is known in the art, for example, it usually accounts for 0.5-10% of the total weight of the component (C).
所述增稠剂的实例包括但不限于卡波姆类、丙烯酸(酯)类及其衍生物、黄原胶、阿拉伯胶、聚乙二醇-14M、聚乙二醇-90M、琥珀酰聚糖、羟乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素等高分子聚合物中的一种或多种。所述增稠剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.1-10%。Examples of the thickener include, but are not limited to, carbomers, acrylic acid (ester) and its derivatives, xanthan gum, gum arabic, polyethylene glycol-14M, polyethylene glycol-90M, succinyl poly One or more of high molecular polymers such as sugar, hydroxyethyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose. The content of the thickener in the external skin composition is known in the art, for example, it usually accounts for 0.1-10% of the total weight of the component (C).
所述防腐剂的实例包括但不限于羟苯甲酯、羟苯乙酯、羟苯丙酯、苯氧乙醇、苯甲醇、苯乙醇、双(羟甲基)咪唑烷基脲、山梨酸钾、苯甲酸钠、氯苯甘醚、脱氢乙酸钠等中的一种或多种。所述防腐剂在所述皮肤外用组合物中的含量是本领域已知的,例如,其通常占组分(C)总重量的0.01-50%。Examples of the preservatives include, but are not limited to, methyl paraben, ethyl paraben, propyl paraben, phenoxyethanol, benzyl alcohol, phenethyl alcohol, bis(hydroxymethyl)imidazolidinyl urea, potassium sorbate, One or more of sodium benzoate, chlorphenesin, sodium dehydroacetate, etc. The content of the preservative in the skin external composition is known in the art, for example, it usually accounts for 0.01-50% of the total weight of the component (C).
本发明的皮肤外用组合物可以通过本领域已知的任何合适的方法制备。例如,使用化 妆品领域中常用的溶解槽、乳化锅、分散器、输送泵等设备制备。制备时先将水溶性物质投入水相溶解釜,将油溶性物质投入油相溶解釜,将两个釜的温度加热至约80℃,其中对于易结块的原料,可先用分散器将其预分散。待溶解完成后将油相和水相输送至乳化锅中,均质乳化约5-15分钟。乳化完成后将料体温度降至常温,加入任选的香精、防腐剂等,并视需要调节产物的pH。相关检测指标都合格后方可灌装出货。The skin external composition of the present invention can be prepared by any suitable method known in the art. For example, it can be prepared using equipment such as dissolving tanks, emulsifying pots, dispersers, and delivery pumps commonly used in the cosmetics field. When preparing, put the water-soluble substance into the water-phase dissolving kettle, and the oil-soluble substance into the oil-phase dissolving kettle, and heat the temperature of the two kettles to about 80°C. For the raw materials that are easy to agglomerate, they can be mixed with a disperser first. Pre-dispersion. After the dissolution is completed, the oil phase and the water phase are transported to the emulsifying pot for homogenization and emulsification for about 5-15 minutes. After the emulsification is completed, the temperature of the material body is reduced to normal temperature, optional flavors, preservatives, etc. are added, and the pH of the product is adjusted as necessary. The products can be filled and shipped only after the relevant test indicators are qualified.
以上制备方法可根据剂型要求进行删减或调整。可根据需要制备液体、乳液、膏、霜或凝胶等各种剂型的药物组合物或者化妆品组合物,其中所述化妆品组合物可以是化妆水、喷雾、乳液、精华水或精华乳、BB霜、防晒霜等各种形式。The above preparation methods can be deleted or adjusted according to dosage form requirements. Pharmaceutical compositions or cosmetic compositions in various dosage forms such as liquids, emulsions, creams, creams or gels can be prepared according to needs, wherein the cosmetic compositions can be lotions, sprays, emulsions, essence water or essence milk, BB cream , Sunscreen and other forms.
实施例Example
以下结合实施例,对本发明进行进一步详细说明。但是,应当理解为,这些实施例、对比例仅仅是用于更详细地说明本发明,而不应理解为用于以任何形式限制本发明所附权利要求书的范围。Hereinafter, the present invention will be further described in detail with reference to the embodiments. However, it should be understood that these examples and comparative examples are only used to describe the present invention in more detail, and should not be understood as limiting the scope of the appended claims of the present invention in any form.
实施例1:5α-还原酶活力的抑制 Example 1 : Inhibition of 5α-reductase activity
在本实施例中,考察和对比了不同浓缩倍数的桦树汁、水杨酸、苹果酸,以及它们的组合对5α-还原酶活性的影响。In this example, the effects of birch sap, salicylic acid, malic acid, and their combination on the activity of 5α-reductase of different concentration multiples were investigated and compared.
1.桦树汁的浓缩1. Concentration of birch sap
将购自大兴安岭超越野生浆果开发有限责任公司的新鲜白桦树汁原液输入低温干燥设备,降温至-65℃,抽真空至0.1Pa,浓缩2和10倍。The fresh white birch sap stock solution purchased from Daxinganling Chaoyue Wild Berry Development Co., Ltd. is fed into the low-temperature drying equipment, the temperature is reduced to -65°C, the vacuum is reduced to 0.1Pa, and the concentration is 2 and 10 times.
2.测试2. Test
实验仪器:天平、破壁机、恒温振荡器、高速冷冻离心机、酶标仪。Experimental instruments: balance, wall breaker, constant temperature oscillator, high-speed refrigerated centrifuge, microplate reader.
实验试剂与耗材:Experimental reagents and consumables:
非那雄胺:上海现代制药股份有限公司(片剂5mg/片);Finasteride: Shanghai Modern Pharmaceutical Co., Ltd. (tablet 5mg/tablet);
还原型辅酶Ⅱ(NADPH):美国Roche公司(粉剂10mg);Reduced coenzyme Ⅱ (NADPH): American Roche company (powder 10mg);
睾酮Elisa试剂盒:武汉优尔生公司(货号:CEA458Ge);Testosterone Elisa kit: Wuhan Ulsheng Company (Cat. No.: CEA458Ge);
5α-还原酶粗酶:自备;5α-reductase crude enzyme: self-provided;
PBS:武汉博士德公司;PBS: Wuhan Boster Company;
苯甲基磺酰氟(PMSF):美国Sigma公司;Phenylmethylsulfonyl fluoride (PMSF): American Sigma company;
二硫苏糖醇(DTT):美国Sigma公司;Dithiothreitol (DTT): American Sigma company;
1M Tris-HCl:武汉博士德公司。1M Tris-HCl: Wuhan Boster Company.
样品加样信息:Sample adding information:
单一原料上样量为一整份原料;复配原料为半份桦树汁原料加半份0.1%的其它活性原料。The sample amount of a single raw material is one whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
体外5α-还原酶活性影响分析步骤如下:In vitro 5α-reductase activity influence analysis steps are as follows:
(1)粗酶制备:取正常健康小鼠5只,颈部脱臼致死,打开腹腔,取其睾丸,分为数份,置于2mLEP管中,按1:4比例加入适量粗酶提取液,于4℃下破壁机破碎制成匀浆液,4℃高速冷冻离心(10000rpm/分钟,10分钟),取其上清液4℃保存。BCA法测定蛋白浓度,1mg/mL以上即可进行后续实验;(1) Preparation of crude enzyme: Take 5 normal healthy mice, let their necks dislocated to death, open the abdominal cavity, take their testes, divide them into several portions, place them in a 2mL EP tube, add an appropriate amount of crude enzyme extract in a ratio of 1:4, The homogenate was crushed by a wall breaker at 4°C and centrifuged at a high speed at 4°C (10000rpm/min, 10 minutes), and the supernatant was stored at 4°C. BCA method is used to determine protein concentration, and follow-up experiments can be carried out after 1 mg/mL;
(2)空白对照的测定:分别取2组200μLEP管(每组4个),均加入5α-还原酶粗酶、PBS溶液(pH=7.4)、还原型辅酶Ⅱ,一组混合后立即放入沸水中煮沸5分钟,离心后吸取50μL液体进行后续Elisa检测,为空白对照组起始睾酮含量;另一组混合后放置恒温摇床中混匀60分钟,放入沸水中煮沸5分钟,离心后吸取50μL液体进行后续Elisa检测,其与起始含量的差值为空白对照组转化后睾酮含量;(2) Determination of blank control: Take 2 groups of 200μLEP tubes (4 in each group), add 5α-reductase crude enzyme, PBS solution (pH=7.4), reduced coenzyme II, and put them in immediately after mixing. Boil in boiling water for 5 minutes. After centrifugation, 50μL of liquid is drawn for subsequent Elisa detection, which is the initial testosterone content of the blank control group; the other group is mixed and placed in a constant temperature shaker for 60 minutes, put in boiling water and boiled for 5 minutes, after centrifugation Aspirate 50μL of liquid for subsequent Elisa detection, and the difference from the initial content is the testosterone content of the blank control group after transformation;
(3)样品组的测定:分别取2组200μL EP管(每组4个),均加入5α-还原酶粗酶、PBS溶液(pH=7.4)、还原型辅酶Ⅱ和测试原料,一组混合后立即放入沸水中煮沸5分钟,离心后吸取50μL液体进行后续Elisa检测,为抑制剂组起始睾酮含量;另一组混合后放置恒温摇床中混匀60分钟,放入沸水中煮沸5分钟,离心后吸取50μL液体进行后续Elisa检测,其与起始含量的差值为抑制剂组转化后睾酮含量。实验每次4个平行样。(3) Determination of sample group: Take 2 groups of 200μL EP tubes (4 in each group), add 5α-reductase crude enzyme, PBS solution (pH=7.4), reduced coenzyme II and test materials, and mix in one group Immediately put it in boiling water and boil for 5 minutes. After centrifugation, 50μL of liquid was drawn for subsequent Elisa detection, which is the initial testosterone content of the inhibitor group; the other group was mixed and placed in a constant temperature shaker to mix for 60 minutes, and then boiled in boiling water for 5 After centrifugation, 50 μL of liquid was drawn for subsequent Elisa detection. The difference between the initial content and the testosterone content of the inhibitor group was the testosterone content after conversion. Each experiment has 4 parallel samples.
5α-还原酶抑制率按如下公式计算:The inhibition rate of 5α-reductase is calculated according to the following formula:
I%=(△A 0-△A n)/△A 0x100% I%=(△A 0 -△A n )/△A 0 x100%
其中:among them:
△A 0----对照组睾酮减少量; △A 0 ---- Decrease of testosterone in the control group;
△A n----抑制剂组睾酮减少量。 △A n ---- Decrease of testosterone in inhibitor group.
测试结果如下表所示。The test results are shown in the table below.
样品sample 抑制率Inhibition rate
桦树汁原液Birch sap 19%±2%19%±2%
2倍浓缩桦树汁2 times concentrated birch sap 48%±4%48%±4%
10倍浓缩桦树汁10 times concentrated birch sap 26%±3%26%±3%
水杨酸Salicylic acid 10%±1%10%±1%
苹果酸Malic acid 9%±1%9%±1%
桦树汁原液+水杨酸Birch sap extract + salicylic acid 35%±6%35%±6%
桦树汁原液+苹果酸Birch sap extract + malic acid 38%±5%38%±5%
2倍浓缩桦树汁+水杨酸2 times concentrated birch sap + salicylic acid 68%±9%68%±9%
2倍浓缩桦树汁+苹果酸2 times concentrated birch sap + malic acid 77%±7%77%±7%
10倍浓缩桦树汁+水杨酸10 times concentrated birch sap + salicylic acid 32%±3%32%±3%
10倍浓缩桦树汁+苹果酸10 times concentrated birch juice + malic acid 34%±5%34%±5%
以上结果表明,在抑制5α-还原酶方面,2倍浓缩桦树汁与水杨酸或苹果酸的组合使用的效果显著优于单独使用桦树汁原液、2倍浓缩桦树汁及水杨酸或苹果酸,同时也显著 优于桦树汁原液和水杨酸或苹果酸的组合物。当桦树汁浓缩到10倍时,与其它活性物组合使用的效果则明显减弱,甚至不及桦树汁原液与其它活性物原料的组合效果。The above results show that in terms of inhibiting 5α-reductase, the combination of 2 times concentrated birch sap and salicylic acid or malic acid is significantly better than using birch sap stock solution, 2 times concentrated birch sap and salicylic acid alone. Or malic acid, which is also significantly better than the combination of birch sap and salicylic acid or malic acid. When the birch sap is concentrated to 10 times, the effect of using it in combination with other active substances is significantly weakened, and is even inferior to the combined effect of birch sap stock and other active ingredients.
实施例2:抑菌实验 Example 2 : Antibacterial Experiment
根据QB/T 2738-2012日化产品抗菌抑菌效果的评价方法,对不同浓度桦树汁、PCA锌,以及它们的组合物进行抑菌环法测定。According to the QB/T 2738-2012 method for evaluating the antibacterial and antibacterial effects of daily chemical products, the birch sap, PCA zinc, and their compositions of different concentrations were tested by the antibacterial ring method.
1.实验材料1. Experimental materials
设备及耗材:滤纸(抑菌剂载体);游标卡尺。Equipment and consumables: filter paper (bacteriostatic agent carrier); vernier calipers.
试剂:营养琼脂培养基;菌悬液。Reagents: nutrient agar medium; bacterial suspension.
菌种来源:痤疮丙酸杆菌购自中国典型培养物保藏中心。Source of strain: Propionibacterium acnes was purchased from the China Type Culture Collection.
样品加样信息:单一原料上样量为一整份原料;复配原料为半份桦树汁原料加半份0.1%的其它活性原料。Sample addition information: the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
2.测试2. Test
抑菌实验操作步骤:Operation steps of antibacterial experiment:
(1)抑菌片的制备:取5mm直径圆形无菌干燥滤纸片,将液体样品20μL滴加在抑菌片的中央,然后将滤纸片平放于清洁的无菌平皿内,开盖置于恒温箱(37℃)中烘干,或置于室温下自然干燥后备用。(1) Preparation of antibacterial tablets: take a circular sterile dry filter paper with a diameter of 5mm, drop 20μL of liquid sample into the center of the antibacterial tablet, and then place the filter paper flat in a clean sterile plate with the lid open Dry in a constant temperature oven (37°C), or dry naturally at room temperature for later use.
(2)试验菌的接种:用无菌棉拭子蘸取浓度为1×10 4cfu/ml~9×10 4cfu/ml试验菌悬液,在营养琼脂培养基平板表面均匀涂抹3次。每涂抹1次,平板应转动60度,最后用棉拭子绕平板边缘涂抹一周。盖好平皿,置于室温干燥5分钟。 (2) Inoculation of test bacteria: dip a sterile cotton swab into a test bacteria suspension with a concentration of 1×10 4 cfu/ml to 9×10 4 cfu/ml, and smear it evenly on the surface of the nutrient agar medium plate 3 times. After each application, the plate should be rotated 60 degrees, and finally use a cotton swab to apply a circle around the edge of the plate. Cover the plate and let it dry at room temperature for 5 minutes.
(3)抑菌试验样品贴放:每次试验贴放1个染菌平板,每个平板贴放4片试验样片,1片对照样片,共计5片。用无菌镊子去样片贴放于平板表面,各样片中心之间相距25mm以上,与平板的周缘相距15mm以上。贴放好后,用无菌镊子轻压样片,使其紧贴于平板表面,盖好平皿,置于37℃恒温箱,培养16~18小时后观察结果。用游标卡尺测量抑菌环的直径(包括贴片)并记录。试验重复3次。(3) Placement of antibacterial test samples: Place 1 stained plate for each test, 4 pieces of test specimens for each plate, 1 piece of control specimens, a total of 5 pieces. Use sterile tweezers to remove the samples and place them on the surface of the plate. The distance between the centers of the samples is more than 25mm and the distance between the centers of the samples is more than 15mm. After the paste is placed, use sterile tweezers to gently press the sample piece to make it close to the surface of the plate, cover the plate, place it in a 37°C incubator, and observe the results after incubating for 16 to 18 hours. Measure the diameter of the antibacterial ring (including the patch) with a vernier caliper and record it. The test was repeated 3 times.
测试结果如下表所示。The test results are shown in the table below.
样品sample 痤疮丙酸杆菌抑菌圈直径/mmDiameter of inhibition zone of Propionibacterium acnes/mm
空白blank 00
桦树汁原液Birch sap 12±212±2
2倍浓缩桦树汁2 times concentrated birch sap 25±425±4
10倍浓缩桦树汁10 times concentrated birch sap 15±315±3
PCA锌PCA zinc 8±18±1
桦树汁原液+PCA锌Birch sap extract + PCA zinc 20±320±3
2倍浓缩桦树汁+PCA锌2 times concentrated birch sap + PCA zinc 38±538±5
10倍浓缩桦树汁+PCA锌10 times concentrated birch sap + PCA zinc 18±518±5
抑菌测试结果表明,与单独使用桦树汁原液、2倍浓缩桦树汁、PCA锌,以及桦树汁 原液和PCA锌的组合相比,2倍浓缩桦树汁与PCA锌的组合使用显著提高了抑制痤疮丙酸杆菌生长的能力。当桦树汁浓缩到10倍时,与其它活性物组合使用的效果则明显减弱,甚至不及桦树汁原液与其它活性物原料的组合效果。Bacteriostatic test results showed that the combined use of birch sap concentrate and PCA zinc was significantly greater than the combination of birch sap concentrate, birch sap concentrate, PCA zinc, and the combination of birch sap concentrate and PCA zinc alone. Improved the ability to inhibit the growth of Propionibacterium acnes. When the birch sap is concentrated to 10 times, the effect of using it in combination with other active substances is significantly weakened, and is even inferior to the combined effect of birch sap stock and other active ingredients.
实施例3:大鼠耳廓模型实验 Example 3 : Rat ear pinna model experiment
在本实施例中,基于鼠耳廓模型实验,分别考察了不同浓度桦树汁和芦荟提取物、绿茶提取物、尿囊素、烟酰胺,以及它们的组合物对抗血清中IL-1α、TNF-α的能力。In this example, based on the mouse ear model experiment, different concentrations of birch sap and aloe extract, green tea extract, allantoin, nicotinamide, and their combinations were tested against serum IL-1α and TNF. -Alpha ability.
1.材料1. Material
实验动物:SPF级SD雄性健康大鼠,体质量(200±20)g,由浙江省医科院提供。Experimental animals: SPF-grade SD male healthy rats, weighing (200±20) g, provided by Zhejiang Medical Academy.
药物和试剂:100%油酸;ELISA IL-1α试剂盒;ELISA TNF-α试剂盒。Drugs and reagents: 100% oleic acid; ELISA IL-1α kit; ELISA TNF-α kit.
样品加样信息:单一原料上样量为一整份原料;复配原料为半份桦树汁原料加半份0.1%的其它活性原料。Sample addition information: the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
2.方法2. Method
(1)造模方法将大鼠随机分为2组,其中正常组8只,其余为造模组。于造模组每只大鼠右耳廓皮内,用1ml注射器均匀涂抹100%油酸,1次/天,每次约0.3ml,连续涂抹3周。涂100%油酸至第22天,随机抽取2只造模大鼠,切下右耳涂油酸处的2个耳片,以10%甲醛固定,石蜡包埋,切片,HE染色,在光镜下观察组织病理学改变。光镜下观察可见:角质层增厚,呈角化过度,毛囊扩张,毛囊口及漏斗部充满角化物质,角栓堵塞,扩大呈壶状,皮脂腺消失。依照实验性粉刺组织学判定分级标准,提示大鼠耳廓实验性痤疮模型已形成。(1) Modeling method The rats were randomly divided into 2 groups, of which 8 were in the normal group and the rest were modeled. Apply 100% oleic acid into the skin of each rat's right auricle with a 1ml syringe, once a day, about 0.3ml each time for 3 weeks. Apply 100% oleic acid to the 22nd day, randomly select 2 model rats, cut off the 2 ears of the right ear where the oleic acid is applied, fix with 10% formaldehyde, embed in paraffin, section, HE stain, light Observe histopathological changes under the microscope. Observation under the light microscope shows that the stratum corneum is thickened, hyperkeratosis, the hair follicle is expanded, the mouth and funnel of the hair follicle are filled with keratinized material, the horn plug is blocked, and the expansion is pot-shaped, and the sebaceous gland disappears. According to the grading standard of experimental acne histology, it is suggested that the experimental acne model of rat auricle has been formed.
(2)动物分组与给药造模成功后,将造模组剩余大鼠,按体质量随机分为模型空白组和不同浓度的桦树汁组,每组8只。实验第22天,开始外用涂抹给药。各组给药量均为涂抹0.1ml,给药部位均为大鼠右耳廓造模处,1次/天,连续给药2周。正常组和模型组均不涂抹任何药物。(2) Animal grouping and drug administration After successful modeling, the remaining rats in the model were randomly divided into a blank model group and a birch sap group with different concentrations, with 8 rats in each group. On the 22nd day of the experiment, topical smearing was started. The dosage of each group was smeared 0.1ml, and the administration site was the model site of the right auricle of the rat, once a day, for 2 weeks. No drugs were applied to the normal group and model group.
(3)标本的收集及检测方法末次给药24小时后,取各组动物的股动脉血,分离血清,-20℃保存备用。血清IL-1α、TNF-α含量的测定采用双抗体夹心ABC-ELISA法。(3) Collection and detection methods of specimens 24 hours after the last administration, the femoral artery blood of each group of animals was taken, serum was separated, and stored at -20°C for later use. The serum IL-1α and TNF-α levels were determined by the double antibody sandwich ABC-ELISA method.
(4)应用GraphPad Prism Program软件作图,各组间采用T-test统计分析。(4) GraphPad Prism Program software was used for drawing, and T-test statistical analysis was used between groups.
测试结果如下表所示。The test results are shown in the table below.
样品sample 只数Only count IL-1α(ng/ml)IL-1α(ng/ml) TNF-α(ng/ml)TNF-α(ng/ml)
正常组normal group 88 14.36±0.3914.36±0.39 6.31±1.526.31±1.52
模型组Model group 88 22.56±1.3222.56±1.32 22.47±0.6522.47±0.65
桦树汁原液Birch sap 88 19.83±1.03*19.83±1.03* 18.50±1.34*18.50±1.34*
2倍浓缩桦树汁2 times concentrated birch sap 88 17.65±0.88**17.65±0.88** 14.34±0.86**14.34±0.86**
10倍浓缩桦树汁10 times concentrated birch sap 88 19.99±1.22*19.99±1.22* 18.48±1.80*18.48±1.80*
芦荟提取物Aloe extract 88 20.36±1.03*20.36±1.03* 17.93±1.48*17.93±1.48*
绿茶提取物Green tea extract 88 19.22±1.03*19.22±1.03* 19.05±1.93*19.05±1.93*
尿囊素Allantoin 88 19.01±2.16*19.01±2.16* 18.47±1.65*18.47±1.65*
烟酰胺Nicotinamide 88 20.68±2.02*20.68±2.02* 19.54±1.05*19.54±1.05*
桦树汁原液+芦荟提取物Birch sap extract + aloe extract 88 16.98±1.54**16.98±1.54** 13.81±1.22**13.81±1.22**
桦树汁原液+绿茶提取物Birch tree juice extract + green tea extract 88 17.32±0.99**17.32±0.99** 15.46±0.98**15.46±0.98**
桦树汁原液+尿囊素Birch sap extract + allantoin 88 16.33±1.87**16.33±1.87** 12.55±0.74**12.55±0.74**
桦树汁原液+烟酰胺Birch sap extract + niacinamide 88 17.64±1.22**17.64±1.22** 14.74±0.55**14.74±0.55**
2倍桦树汁原液+芦荟提取物2 times birch sap extract + aloe extract 88 14.87±0.82**14.87±0.82** 8.72±0.52**8.72±0.52**
2倍桦树汁原液+绿茶提取物2 times birch tree juice extract + green tea extract 88 14.37±1.31**14.37±1.31** 6.69±1.35**6.69±1.35**
2倍桦树汁原液+尿囊素2 times birch sap extract + allantoin 88 14.85±1.49**14.85±1.49** 7.49±1.51**7.49±1.51**
2倍桦树汁原液+烟酰胺2 times birch sap extract + niacinamide 88 15.62±1.01**15.62±1.01** 6.85±1.44**6.85±1.44**
10倍桦树汁原液+芦荟提取物10 times birch sap extract + aloe extract 88 17.45±1.65**17.45±1.65** 15.22±1.53**15.22±1.53**
10倍桦树汁原液+绿茶提取物10 times birch tree juice extract + green tea extract 88 18.97±0.87**18.97±0.87** 14.83±0.56**14.83±0.56**
10倍桦树汁原液+尿囊素10 times birch sap extract + allantoin 88 18.21±1.54**18.21±1.54** 16.53±0.98**16.53±0.98**
10倍桦树汁原液+烟酰胺10 times birch sap extract + niacinamide 88 17.43±1.31**17.43±1.31** 15.38±1.35**15.38±1.35**
注:*表示与模型组相比为显著,p值小于0.05;**表示与模型相比为极显著,p值小于0.01。Note: * indicates that it is significant compared with the model group, and the p value is less than 0.05; ** indicates that it is extremely significant compared to the model, and the p value is less than 0.01.
以上结果表明,与单独使用桦树汁原液、2倍浓缩桦树汁、芦荟提取物、绿茶提取物、尿囊素或烟酰胺,以及桦树汁原液和芦荟提取物、绿茶提取物、尿囊素或烟酰胺的组合相比,2倍浓缩桦树汁与芦荟提取物、绿茶提取物、尿囊素或烟酰胺的组合使用显著提高了抗血清中IL-1α、TNF-α的能力。当桦树汁浓缩到10倍时,与其它活性物组合使用的效果则明显减弱,甚至不及桦树汁原液与其它活性物原料的组合效果。The above results show that, compared with the use of birch tree juice stock, 2 times concentrated birch tree juice, aloe extract, green tea extract, allantoin or nicotinamide, as well as birch juice stock and aloe extract, green tea extract, allanto Compared with the combination of nicotin or nicotinamide, the combination of 2 times concentrated birch tree juice and aloe extract, green tea extract, allantoin or nicotinamide significantly improved the ability of antiserum IL-1α and TNF-α. When the birch sap is concentrated to 10 times, the effect of using it in combination with other active substances is significantly weakened, and is even inferior to the combined effect of birch sap stock and other active ingredients.
实施例4:人体皮肤油脂含量 Example 4 : Human skin oil content
在本实施例中,分别考察了不同浓度的桦树汁和PCA锌、透明质酸钠,以及它们的组合物对人体皮肤油脂含量的影响。In this example, the effects of different concentrations of birch tree sap, PCA zinc, sodium hyaluronate, and their composition on the oil content of human skin were investigated.
皮肤油脂分泌过多是导致痤疮的主要原因之一。实验使用皮肤油脂测定仪(德国CK公司SM815)对使用化妆品前后的皮肤油脂腺分泌物进行定量测量,可以对化妆品的抗痤疮功效进行评价。SM815测定原理是基于光度计原理,一种0.1mm厚的特殊消光胶带吸收人体皮肤上的油脂后,就会变成一种半透明的胶带,它的透光量就会发生变化,吸收的油脂越多,透光量就会越大,这样就可以测量出皮肤油脂的含量。Excessive skin oil secretion is one of the main causes of acne. In the experiment, a skin oil tester (SM815, a German CK company) was used to quantitatively measure the skin oil gland secretions before and after using cosmetics, which can evaluate the anti-acne efficacy of cosmetics. The SM815 measurement principle is based on the photometer principle. After a special matt tape with a thickness of 0.1mm absorbs the oil on the human skin, it will become a translucent tape, and its light transmission will change and the absorbed grease The more, the greater the light transmission, so that the content of skin oil can be measured.
样品加样信息:单一原料上样量为一整份原料;复配原料为半份桦树汁原料加半份0.1%的其它活性原料。Sample addition information: the sample amount of a single raw material is a whole raw material; the compound raw material is half a birch sap raw material plus half a 0.1% other active raw material.
实验过程:选用油脂分泌过旺试验患者(20~35岁,男女各一半),试验者平均分组,每组8名,测试油脂当天清洁面部,30分钟后在脸颊涂擦3mg/cm 2的不同产品。分别在第0小时、2小时、4小时、8小时用SM815动态测定皮肤油脂含量,计算皮肤油脂含量变化。 Experimental process: select patients (20 to 35 years old, half male and female) for hypersecretion of oil, the testers are divided into groups, 8 in each group, clean the face on the day of the oil test, and rub 3mg/cm 2 on the cheek after 30 minutes. product. The skin oil content was dynamically measured with SM815 at 0 hour, 2 hours, 4 hours, and 8 hours, respectively, and the skin oil content changes were calculated.
实验评价及试验者均双盲标示法,所测试为恒温恒湿实验室中进行,温度为25±1℃,湿度为60%±5%。Both the experiment evaluation and the testers were double-blind labeling method, and the test was carried out in a constant temperature and humidity laboratory with a temperature of 25±1°C and a humidity of 60%±5%.
测试结果如下表所示。The test results are shown in the table below.
Figure PCTCN2020102233-appb-000001
Figure PCTCN2020102233-appb-000001
对照组皮肤油脂含量随时间逐渐升高,表明试验者油脂分泌旺盛。样品组结果表明,与单独使用桦树汁原液、2倍浓缩桦树汁、PCA锌、透明质酸钠,以及桦树汁原液和PCA锌或透明质酸钠的组合相比,2倍浓缩桦树汁与PCA锌或透明质酸钠的组合使用更加显著抑制了测试者的油脂过盛分泌。当桦树汁浓缩到10倍时,与其它活性物组合使用的效果则明显减弱,甚至不及桦树汁原液与其它活性物原料的组合效果。The skin oil content of the control group gradually increased over time, indicating that the tester had strong oil secretion. The results of the sample group showed that compared with the birch sap stock solution alone, the birch sap of 2 times concentrated birch sap, PCA zinc, sodium hyaluronate, and the combination of birch sap stock and PCA zinc or sodium hyaluronate, the birch sap was 2 times concentrated. The combined use of tree sap and PCA zinc or sodium hyaluronate more significantly inhibited the tester’s excessive oil secretion. When the birch sap is concentrated to 10 times, the effect of using it in combination with other active substances is significantly weakened, and is even inferior to the combined effect of birch sap stock and other active ingredients.
实施例5:祛痘精华乳的制备和性能考察 Example 5 : Preparation and performance investigation of anti-acne essence milk
包含不同活性物的祛痘精华乳配方如下表所示:The formula of anti-acne essence milk containing different active substances is shown in the following table:
Figure PCTCN2020102233-appb-000002
Figure PCTCN2020102233-appb-000002
制备过程如下:称取A相原料,将A相中的各组分混合均匀并确保组分溶解完全,加热至60℃,保温20分钟。边搅拌边降温至45℃时,依次加入B相,搅拌均匀,得到上述多种祛痘精华乳产品。The preparation process is as follows: Weigh the raw materials of phase A, mix the components in phase A uniformly and ensure that the components are completely dissolved, heat to 60°C and keep it for 20 minutes. When the temperature is lowered to 45°C while stirring, add phase B one by one and stir evenly to obtain the above-mentioned various acne-removing essence milk products.
为测试产品的实际使用效果,对上述不同祛痘精华乳产品分别进行了人群试用调查,派发样品给有痘患者试用,年龄20-35岁,每种产品受试者为60人,试用1个月,同时填写调查问卷,最后统计结果。In order to test the actual use effect of the product, the above-mentioned different acne essence milk products were tested separately, and samples were distributed to patients with acne, aged 20-35 years old, 60 people for each product, one trial Month, fill out the questionnaire at the same time, and finally count the results.
分级判定的标准如下:The classification criteria are as follows:
显著有效:痊愈或皮损消退>60%Significantly effective: recovery or skin lesions subsided>60%
有效:皮损消退20%~60%Effective: 20%~60% of skin lesions subsided
无效:皮损消退<20%或加重。Invalid: skin lesions subsided <20% or worsened.
人群试用调查结果如下。The results of the population trial survey are as follows.
样品sample 显著有效/例Significantly effective/case 有效/例Effective/case 无效/例Invalid/case
空白样Blank sample 00 33 5757
桦树汁原液Birch sap 24twenty four 1414 22twenty two
2倍浓缩桦树汁2 times concentrated birch sap 3030 1212 1818
水杨酸Salicylic acid 1111 1414 3535
桦树汁原液+水杨酸Birch sap extract + salicylic acid 3131 1515 1414
2倍桦树汁原液+水杨酸2 times birch sap extract + salicylic acid 3838 1414 88
以上结果表明,与单独使用含有桦树汁原液、2倍浓缩桦树汁、水杨酸,以及桦树汁原液和水杨酸的组合的祛痘精华乳相比,含2倍浓缩桦树汁与水杨酸的组合的精华乳具有更为显著的祛痘能力。The above results show that compared with the single use of birch tree juice concentrate, birch tree juice concentrate, salicylic acid, and a combination of birch tree juice concentrate and salicylic acid, it contains two times more concentrated birch juice Essence milk combined with salicylic acid has a more pronounced anti-acne ability.
以上所述实施例的技术方案是本发明优选实施方式,在不脱离本发明原理的前提下还可以进行若干改进和变换,这些改进和变化也应视为在本发明的保护范围内。The technical solutions of the above-mentioned embodiments are preferred implementations of the present invention. Several improvements and changes can be made without departing from the principle of the present invention, and these improvements and changes should also be regarded as falling within the protection scope of the present invention.

Claims (8)

  1. (A)浓缩的桦树汁与(B)选自水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺中的一种或多种的组合在具有祛痘功效的皮肤外用组合物中的用途,其中所述浓缩的桦树汁的浓缩倍数为1.1-8倍,优选1.2-4倍,更优选1.2-2倍。(A) Concentrated birch juice and (B) one or more selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate and nicotinamide The use of the combination of in a skin external composition with anti-acne effect, wherein the concentration of the concentrated birch juice is 1.1-8 times, preferably 1.2-4 times, more preferably 1.2-2 times.
  2. 权利要求1的用途,其中所述皮肤外用组合物不包含任何外加的水。The use of claim 1, wherein the external skin composition does not contain any added water.
  3. 权利要求1或2的用途,其中所述皮肤外用组合物是药物组合物或化妆品组合物。The use according to claim 1 or 2, wherein the external skin composition is a pharmaceutical composition or a cosmetic composition.
  4. 一种具有祛痘功效的皮肤外用组合物,其包含(A)浓缩的桦树汁,其浓缩倍数为1.1-8倍,优选1.2-4倍,更优选1.2-2倍,和(B)选自水杨酸、苹果酸、芦荟提取物、绿茶提取物、PCA锌、尿囊素、透明质酸钠和烟酰胺中的一种或多种物质。An external skin composition with anti-acne effect, which comprises (A) concentrated birch tree juice, the concentration of which is 1.1-8 times, preferably 1.2-4 times, more preferably 1.2-2 times, and (B) One or more substances selected from salicylic acid, malic acid, aloe extract, green tea extract, PCA zinc, allantoin, sodium hyaluronate, and nicotinamide.
  5. 权利要求4的皮肤外用组合物,其中所述组分(A)浓缩桦树汁的含量为10-98%重量,优选20-98%重量,更优选30-97%重量,基于所述皮肤外用组合物的总重量。The skin external composition of claim 4, wherein the content of the component (A) concentrated birch sap is 10-98% by weight, preferably 20-98% by weight, more preferably 30-97% by weight, based on the skin external application The total weight of the composition.
  6. 权利要求4或5的皮肤外用组合物,其中所述组分(B)的含量为0.0005-30%重量,优选0.001-10%重量,更优选0.1-5%重量,最优选0.5-3%重量,基于所述皮肤外用组合物的总重量。The skin external composition of claim 4 or 5, wherein the content of the component (B) is 0.0005-30% by weight, preferably 0.001-10% by weight, more preferably 0.1-5% by weight, most preferably 0.5-3% by weight , Based on the total weight of the skin external composition.
  7. 权利要求4-6任一项的皮肤外用组合物,其中所述皮肤外用组合物不包含任何外加的水。The external skin composition according to any one of claims 4-6, wherein the external skin composition does not contain any added water.
  8. 权利要求4-7任一项的皮肤外用组合物,其中所述皮肤外用组合物是药物组合物或者化妆品组合物。The external skin composition according to any one of claims 4-7, wherein the external skin composition is a pharmaceutical composition or a cosmetic composition.
PCT/CN2020/102233 2019-07-30 2020-07-16 External skin composition having anti-acne effect WO2021017839A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022506271A JP7422214B2 (en) 2019-07-30 2020-07-16 Skin topical compositions with anti-acne efficacy
KR1020227006692A KR20220044764A (en) 2019-07-30 2020-07-16 External skin composition with anti-acne effect

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910694716.9A CN110731991A (en) 2019-07-30 2019-07-30 Skin external composition with acne removing effect
CN201910694716.9 2019-07-30

Publications (1)

Publication Number Publication Date
WO2021017839A1 true WO2021017839A1 (en) 2021-02-04

Family

ID=69267760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/102233 WO2021017839A1 (en) 2019-07-30 2020-07-16 External skin composition having anti-acne effect

Country Status (4)

Country Link
JP (1) JP7422214B2 (en)
KR (1) KR20220044764A (en)
CN (1) CN110731991A (en)
WO (1) WO2021017839A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113197835A (en) * 2021-05-11 2021-08-03 广州研智化妆品有限公司 Acne removing additive and skin care product
CN117243844A (en) * 2023-11-16 2023-12-19 成都普什制药有限公司 Collagen-containing skin care product essence and preparation method and application thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110731924B (en) * 2019-07-30 2022-05-17 浙江养生堂天然药物研究所有限公司 Enhanced anti-aging cosmetic compositions
CN110731991A (en) * 2019-07-30 2020-01-31 浙江养生堂天然药物研究所有限公司 Skin external composition with acne removing effect
CN110731974B (en) * 2019-07-30 2022-09-02 浙江养生堂天然药物研究所有限公司 Skin external composition with enhanced anti-inflammatory efficacy
CN110731922B (en) * 2019-07-30 2022-08-02 浙江养生堂天然药物研究所有限公司 Enhanced hair loss prevention and hair growth promoting composition
CN111671692A (en) * 2020-07-16 2020-09-18 泉后(广州)生物科技研究院有限公司 Acne-removing composition and preparation method and application thereof
CN113413356A (en) * 2021-05-07 2021-09-21 广州摩亚方舟贸易有限公司 Peach tocol-based acne-removing composition and preparation method thereof
WO2023249017A1 (en) * 2022-06-20 2023-12-28 丸善製薬株式会社 Anti-aging agent, hair growth agent, and anti-androgen agent
CN116459191A (en) * 2023-05-08 2023-07-21 深圳市理然化妆品有限公司 Oil-control moisturizing composition and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110731991A (en) * 2019-07-30 2020-01-31 浙江养生堂天然药物研究所有限公司 Skin external composition with acne removing effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008074796A (en) * 2006-09-22 2008-04-03 Just World Inc Antidiabetic food
JP6180822B2 (en) * 2013-06-28 2017-08-16 ロート製薬株式会社 Pharmaceutical composition
EP3349565A4 (en) * 2015-09-17 2019-05-08 Nordic Koivu Oy Method and apparatus for collecting sap
CN108670878B (en) * 2018-08-01 2021-06-04 养生堂(安吉)化妆品有限公司 Cosmetic composition for resisting skin allergy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110731991A (en) * 2019-07-30 2020-01-31 浙江养生堂天然药物研究所有限公司 Skin external composition with acne removing effect

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
"All You Need to Know to Build Your Skincare Routine", 30 September 2015, BEIJING TIMES CHINESE PRESS, CN, ISBN: 978-7-5699-0340-9, article LI, SHIHONG: "All You Need to Know to Build Your Skincare Routine", pages: 22 - 23, XP009525733 *
"TCM in Cosmetics", 30 November 2006, CHINA PRESS OF TRADITIONAL CHINESE MEDICINE, CN, ISBN: 7-80231-091-1, article LIU, HUAGANG: "Passage; TCM in Cosmetics", pages: 90 - 91, XP009525730 *
"The Best Skin of Your Life Starts Here: Busting Beauty Myths So You Know What to Use and Why (Chinese Edition)", 30 April 2017, GUANGXI NORMAL UNIVERSITY PRESS, CN, ISBN: 978-7-5495-9582-2, article PAULA BEGOUN: "Materials with Skin-Like Structure/Skin Repair Ingredients", pages: 1 - 3, XP009525734 *
ANONYMOUS: "Local Food Safety Standards: Silver Birch (Betula Pendula) Sap Concentrate", LOCAL STANDARDS IN HEILONGJIANG, vol. DS23, 19 December 2018 (2018-12-19), pages 1 - 8, XP009525688 *
H KALLIO , T KARPPINEN , B HOLMBOM: "Concentration of Birch Sap by Reverse Osmosis", JOURNAL OF FOOD SCIENCE, vol. 50, no. 5, 1 September 1985 (1985-09-01), pages 1330 - 1332, XP055776291, ISSN: 0022-1147, DOI: 10.1111/j.1365-2621.1985.tb10470.x *
JIANG, ZHONGHAI: "Study on the Birch Juice in Heilongjiang", SCIENCE AND TECHNOLOGY OF FOOD INDUSTRY, vol. 23, no. 10, 31 October 2002 (2002-10-31), pages 62 - 63, XP009525685, DOI: 10.13386/j.issn1002-0306.2002.10.024 *
LI XIAODI: "The Formula Development of Synergism in Coordination Anti-acne Series Cosmetics", FLAVOUR FRAGRANCE COSMETICS, no. 3, 30 June 2007 (2007-06-30), pages 40 - 45, XP055776290 *
XIANG LEIHONG : " Progress in the Treatments of Acne", JOURNAL OF DIAGNOSIS AND THERAPY ON DERMATO-VENEREOLOGY, vol. 24, no. 4, 31 August 2017 (2017-08-31), pages 277 - 231, XP009525727, ISSN: 1674-8468, DOI: 10.3969 /j.issn.1674-8468.2017.04.002 *
YANG, LIJUAN : "Development and Utilization of Birch Sap Storage in Dongfanghong Forestry", JOURNAL OF HEILONGJIANG VOCATIONAL INSTITUTE OF ECOLOGICAL ENGINEERING, vol. 21, no. 4, 31 July 2008 (2008-07-31), pages 19 - 20, XP009525689, ISSN: 1674-6341 *
ZHU JIELIAN : " Formulation Design for Anti-Acne Products", CHINA COSMETICS REVIEW, no. 7, 31 December 2006 (2006-12-31), pages 74 - 77, XP009525726, ISSN: 1004-5163 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113197835A (en) * 2021-05-11 2021-08-03 广州研智化妆品有限公司 Acne removing additive and skin care product
CN113197835B (en) * 2021-05-11 2023-01-31 广州研智化妆品有限公司 Acne removing additive and skin care product
CN117243844A (en) * 2023-11-16 2023-12-19 成都普什制药有限公司 Collagen-containing skin care product essence and preparation method and application thereof

Also Published As

Publication number Publication date
JP2022552584A (en) 2022-12-19
CN110731991A (en) 2020-01-31
KR20220044764A (en) 2022-04-11
JP7422214B2 (en) 2024-01-25

Similar Documents

Publication Publication Date Title
WO2021017839A1 (en) External skin composition having anti-acne effect
WO2021017878A1 (en) Composition with acne removal effect for external application to skin
JP6608561B2 (en) Skin care cosmetic composition
CN114306171B (en) Topical skin composition and use thereof
US20060251741A1 (en) Stable, homogeneous natural product extracts containing polar and apolar fractions
KR101964809B1 (en) Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof
WO2021017911A1 (en) Enhanced hair loss prevention and hair growth promotion composition
EP2788010B1 (en) Skin care formulation
WO2021103581A1 (en) Skin topical composition having efficacy of promoting wound healing and/or scar repair
CN101588787B (en) Anti-wrinkle agent and ADAM inhibitor
WO2021017910A1 (en) External skin treatment composition with enhanced anti-inflammatory effect
WO2021017835A1 (en) Enhanced whitening cosmetic composition
CN101084000A (en) External skin agent comprising modified clay for preventing inflammation
JPH07126149A (en) Cosmetic composition for beautifying and whitening
JP2001288066A (en) Skin barrier function ameliorator
CN101039650B (en) Prevention or improvement of wrinkles by using ADAM activation inhibitor
JP2001039848A (en) Skin lotion
WO2007094533A1 (en) Composition for inhibiting collagen degradation and promoting collagen synthesis comprising emodin
JPH11106311A (en) Hyaluronidase activity inhibitor and its use
KR20010018805A (en) Cosmetic compositions for anti-inflammation and anti-irritation containing ponciri fructus extracts as effective ingredients
JP3319870B2 (en) Skin external composition and bath agent
JP3974003B2 (en) Hair growth material and external preparation for skin containing the same
JP2005029494A (en) Melanocyte proliferation inhibitor and cosmetic containing the same
JP2002145754A (en) Skin cosmetic
EP0717613B1 (en) Stable composition containing wheat sprout juice and process for producing it

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20848594

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022506271

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20227006692

Country of ref document: KR

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 20848594

Country of ref document: EP

Kind code of ref document: A1